Abstract
BackgroundWe performed a clinical trial to evaluate safety and immunogenicity of a novel long peptide vaccine administered in combinations of incomplete Freund’s adjuvant (IFA) and agonists for TLR3 (polyICLC) and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have